Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Active, not recruiting · NCT03743649 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care | Confusion, Disease Attributes, Neoplasm Metastasis, Neoplastic Processes, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Signs and Symptoms, cognitive disorder, delirium, metastatic malignant neoplasm, neoplasm, nervous system disorder, psychiatric disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-15 | NCT03743649 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| National Cancer Institute (NCI) | 3015 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hosptial de Cancer de Barretos | Barretos | Brazil | 1 |
| M D Anderson Cancer Center | Houston | United States | 667 |
| Virginia Commonwealth University/Massey Cancer Center | Richmond | United States | 58 |